Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing
Conditions
Cutaneous Lymphoma - Other Skin Disorders - Mycosis Fungoides - Cutaneous T-cell Lymphoma
Conditions: official terms
Hematologic Diseases - Lymphoma - Lymphoma, T-Cell - Lymphoma, T-Cell, Cutaneous - Mycosis Fungoides - Skin Diseases
Study Type
Observational
Study Phase
N/A
Study Design
Time Perspective: Prospective
Overall Status
Recruiting
Summary
The goal of this study is to identify genetic changes associated with the initiation, progression, and treatment response of response of cutaneous and hematologic disorders using recently developed high-throughput sequencing technologies. The improved understanding of the genetic changes associated with cutaneous and hematologic disorders may lead to improved diagnostic, prognostic and therapeutic options for these disorders.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Both
Criteria: Inclusion Criteria:

- 18 years of age or older

- Patient meets the clinical and/or pathologic criteria for the cutaneous or hematologic disorder being examined.

- Patient is willing to provide skin biopsies and five 10 mL tubes of peripheral blood.

Exclusion Criteria:

- Less than 18 years of age
Location
Stanford University Cancer Institute
Stanford, California, United States
Status: Recruiting
Start Date
June 2011
Completion Date
April 2015
Sponsors
Stanford University
Source
Stanford University
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page